Endophthalmitis most often caused by Staphylococcus

Article

Endophthalmitis is most often caused by coagulase-negative Staphylococcus, and the antibiotics vancomycin and ceftazidime seem to perform well in treating it. That was one of the findings of a 25-year retrospective study conducted by Dr Ronald C. Gentile, of the New York Eye and Ear Infirmary, and his colleagues in New York City and San Antonio, Texas, USA.

Endophthalmitis is most often caused by coagulase-negative Staphylococcus, and the antibiotics vancomycin and ceftazidime seem to perform well in treating it.

That was one of the findings of a 25-year retrospective study conducted by Dr Ronald C. Gentile, of the New York Eye and Ear Infirmary, and his colleagues in New York City and San Antonio, Texas, USA. The researchers set out to look for trends related to pathogens and antibiotics over the past 25 years. They reported their results in Ophthalmology.

Other findings:

  • Many antibiotics, among them cephalosporins and methicillin, are associated with a statistically significant trend in increasing microbial resistance.
  • A significant trend toward decreasing microbial resistance against aminoglycosides and imipenem also exists.

The researchers studied 911 eyes with a total of 988 consecutive culture-positive endophthalmitis isolates that had been collected from 1987 to 2011. The pathogens they most frequently found were coagulase-negative Staphylococcus (39.4%), Streptococcus viridans species (12.1%) and Staphylococcus aureus (11.1%). Gram-negative organisms accounted for 10.3% of all isolates and fungi accounted for 4.6% of them.

Two isolates, Enterococcus faecium and Nocardia exalbida, were not susceptible to vancomycin, but the rest of the 725 gram-positive bacteria they tested were susceptible. The researchers tested 94 gram-negative organisms against ceftazidime and found that 2 were of intermediate sensitivity and 6 were resistant.

The researchers found that microbial resistance was associated with 8 antibiotics as time went on. Those 8 were ampicillin, cefazolin, cefotetan, ceftriaxone, cephalothin, clindamycin, erythromycin and methicillin/oxacillin. They saw increasing microbial susceptibility with 3 antibiotics: gentamicin, imipenem and tobramycin.

To read the abstract of the study click here.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.